Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149026394> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2149026394 endingPage "930" @default.
- W2149026394 startingPage "928" @default.
- W2149026394 abstract "<h3>Background and aims</h3> Tramadol has become a major cause of drug-induced seizure recently. Naloxone is reported to attenuate the seizurogenic activity of tramadol. Thus, the authors aimed to study the efficacy and safety of naloxone in the management of postseizure complaints. <h3>Methods</h3> This self-controlled study was conducted from August 2006 to August 2008. 59 tramadol intoxicated patients who did have postseizure complaints entered the study. After initial resuscitation and work-up, they received intravenous naloxone 0.05 mg every 3–5 min, and the presence of symptoms, presence of abnormal waves in cerebral state monitor (CSM), cerebral state index (CSI) and optical density (OD) were assessed. <h3>Results</h3> 47 participants completed the study, of whom 43 (91%) had symptom resolution after the intervention, and the presence of symptoms was significantly different before and after the intervention (p<0.001). 47 patients had abnormal waves in the CSM before the intervention, while 15 had abnormal waves in the CSM after intervention (p<0.001). The baseline mean of CSI was 81 (SD: 5.17), which was significantly increased to 92 (SD: 2.35) after naloxone injection (p<0.001). The baseline mean of OD was 7.1 (SD: 0.23), which was significantly increased to 7.7 (SD: 0.29) after naloxone injection (p<0.001). <h3>Conclusion</h3> Naloxone can be considered in the management of postseizure complaints of tramadol toxicity, but further rigorous studies are needed to provide sufficient evidence to support its routine use." @default.
- W2149026394 created "2016-06-24" @default.
- W2149026394 creator A5000765124 @default.
- W2149026394 creator A5015387180 @default.
- W2149026394 creator A5033508547 @default.
- W2149026394 creator A5036806029 @default.
- W2149026394 date "2010-04-08" @default.
- W2149026394 modified "2023-09-24" @default.
- W2149026394 title "Efficacy and safety of naloxone in the management of postseizure complaints of tramadol intoxicated patients: a self-controlled study" @default.
- W2149026394 cites W1526869298 @default.
- W2149026394 cites W1535430789 @default.
- W2149026394 cites W1971011609 @default.
- W2149026394 cites W1991547870 @default.
- W2149026394 cites W1995168545 @default.
- W2149026394 cites W2015240600 @default.
- W2149026394 cites W2063157388 @default.
- W2149026394 cites W2067366123 @default.
- W2149026394 cites W2121692105 @default.
- W2149026394 cites W2134599113 @default.
- W2149026394 cites W2167284689 @default.
- W2149026394 cites W2311442063 @default.
- W2149026394 doi "https://doi.org/10.1136/emj.2009.083162" @default.
- W2149026394 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20378740" @default.
- W2149026394 hasPublicationYear "2010" @default.
- W2149026394 type Work @default.
- W2149026394 sameAs 2149026394 @default.
- W2149026394 citedByCount "20" @default.
- W2149026394 countsByYear W21490263942012 @default.
- W2149026394 countsByYear W21490263942013 @default.
- W2149026394 countsByYear W21490263942014 @default.
- W2149026394 countsByYear W21490263942016 @default.
- W2149026394 countsByYear W21490263942017 @default.
- W2149026394 countsByYear W21490263942019 @default.
- W2149026394 countsByYear W21490263942020 @default.
- W2149026394 countsByYear W21490263942021 @default.
- W2149026394 countsByYear W21490263942022 @default.
- W2149026394 countsByYear W21490263942023 @default.
- W2149026394 crossrefType "journal-article" @default.
- W2149026394 hasAuthorship W2149026394A5000765124 @default.
- W2149026394 hasAuthorship W2149026394A5015387180 @default.
- W2149026394 hasAuthorship W2149026394A5033508547 @default.
- W2149026394 hasAuthorship W2149026394A5036806029 @default.
- W2149026394 hasConcept C118552586 @default.
- W2149026394 hasConcept C126322002 @default.
- W2149026394 hasConcept C170493617 @default.
- W2149026394 hasConcept C2778750930 @default.
- W2149026394 hasConcept C2779777798 @default.
- W2149026394 hasConcept C2780665704 @default.
- W2149026394 hasConcept C2780820201 @default.
- W2149026394 hasConcept C2781063702 @default.
- W2149026394 hasConcept C42219234 @default.
- W2149026394 hasConcept C71924100 @default.
- W2149026394 hasConceptScore W2149026394C118552586 @default.
- W2149026394 hasConceptScore W2149026394C126322002 @default.
- W2149026394 hasConceptScore W2149026394C170493617 @default.
- W2149026394 hasConceptScore W2149026394C2778750930 @default.
- W2149026394 hasConceptScore W2149026394C2779777798 @default.
- W2149026394 hasConceptScore W2149026394C2780665704 @default.
- W2149026394 hasConceptScore W2149026394C2780820201 @default.
- W2149026394 hasConceptScore W2149026394C2781063702 @default.
- W2149026394 hasConceptScore W2149026394C42219234 @default.
- W2149026394 hasConceptScore W2149026394C71924100 @default.
- W2149026394 hasIssue "12" @default.
- W2149026394 hasLocation W21490263941 @default.
- W2149026394 hasLocation W21490263942 @default.
- W2149026394 hasOpenAccess W2149026394 @default.
- W2149026394 hasPrimaryLocation W21490263941 @default.
- W2149026394 hasRelatedWork W2070683333 @default.
- W2149026394 hasRelatedWork W2112295232 @default.
- W2149026394 hasRelatedWork W2287815894 @default.
- W2149026394 hasRelatedWork W2319535247 @default.
- W2149026394 hasRelatedWork W2362277914 @default.
- W2149026394 hasRelatedWork W2518779212 @default.
- W2149026394 hasRelatedWork W2922570616 @default.
- W2149026394 hasRelatedWork W4307328685 @default.
- W2149026394 hasRelatedWork W51507638 @default.
- W2149026394 hasRelatedWork W2423296338 @default.
- W2149026394 hasVolume "27" @default.
- W2149026394 isParatext "false" @default.
- W2149026394 isRetracted "false" @default.
- W2149026394 magId "2149026394" @default.
- W2149026394 workType "article" @default.